The Beauty Health Company (NASDAQ:SKIN) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Analysts give The Beauty Health Company an average recommendation of “Hold” (1 sell, 6 holds, 1 buy) with a 12‑month average price target of $2.42.
• Institutional ownership is very high at 93.26%, and several large investors (Woodline, Millennium, Mirabella) substantially increased their stakes in recent quarters.
• The stock trades around $0.90 (market cap ~$114.7M); the latest quarter slightly beat revenue and EPS estimates but the company remains unprofitable (negative net margin and ROE) with analysts expecting about -$0.25 EPS for the year.

Shares of The Beauty Health Company (NASDAQ:SKIN - Get Free Report) have received an average recommendation of "Hold" from the eight research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $2.42.

Several research firms have recently weighed in on SKIN. Zacks Research upgraded shares of Beauty Health from a "strong sell" rating to a "hold" rating in a research note on Monday, March 16th. Benchmark reiterated a "hold" rating on shares of Beauty Health in a research note on Friday, March 13th. Canaccord Genuity Group restated a "hold" rating and issued a $1.50 price objective on shares of Beauty Health in a research report on Friday, March 13th. TD Cowen cut their price objective on shares of Beauty Health from $1.65 to $1.50 and set a "hold" rating for the company in a research report on Monday, March 16th. Finally, Jefferies Financial Group restated a "hold" rating and issued a $1.60 price objective on shares of Beauty Health in a research report on Wednesday, January 14th.

Hedge Funds Weigh In On Beauty Health

A number of large investors have recently modified their holdings of SKIN. Woodline Partners LP lifted its position in Beauty Health by 255.9% during the third quarter. Woodline Partners LP now owns 5,930,027 shares of the company's stock valued at $11,801,000 after purchasing an additional 4,263,997 shares during the last quarter. Millennium Management LLC lifted its position in Beauty Health by 127.0% during the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company's stock valued at $8,013,000 after purchasing an additional 3,225,668 shares during the last quarter. Mirabella Financial Services LLP lifted its position in Beauty Health by 21.3% during the third quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company's stock valued at $31,037,000 after purchasing an additional 2,734,728 shares during the last quarter. Soleus Capital Management L.P. bought a new stake in Beauty Health during the second quarter valued at approximately $1,910,000. Finally, Geode Capital Management LLC lifted its position in Beauty Health by 27.5% during the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company's stock valued at $4,399,000 after purchasing an additional 496,963 shares during the last quarter. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Price Performance

SKIN opened at $0.90 on Friday. The company has a market capitalization of $114.71 million, a price-to-earnings ratio of -4.49 and a beta of 1.24. The company has a quick ratio of 1.40, a current ratio of 1.66 and a debt-to-equity ratio of 3.94. The firm has a 50-day moving average price of $1.06 and a 200-day moving average price of $1.34. Beauty Health has a twelve month low of $0.76 and a twelve month high of $2.69.

Beauty Health (NASDAQ:SKIN - Get Free Report) last posted its earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. The firm had revenue of $82.37 million during the quarter, compared to the consensus estimate of $78.07 million. Beauty Health had a negative net margin of 3.16% and a negative return on equity of 15.40%. Equities analysts expect that Beauty Health will post -0.25 EPS for the current year.

About Beauty Health

Beauty Health Company NASDAQ: SKIN is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health's brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.